OpenBilldrug price receipt

NADAC week of 2026-10-14

AUSTEDO XR 18 MG TABLET

FDA nonproprietary name: deutetrabenazine

For 30 tablets

Pharmacies pay

$7,534.82 filed

30 × $251.16057 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$6,747.56 filed

30 × $224.9188 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

0.90× estimated

Medicare paid 10% less than pharmacies pay.

Part D averages every strength and form sold under “Austedo XR” / “Deutetrabenazine” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$8,670.04 estimated

$7,534.82 + $1,130.22 (15%) + $5.00 fee per fill = $8,670.04

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

AUSTEDO XR 18 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as deutetrabenazine, under the trade name “AUSTEDO XR”.

FDA gives its dosage form as tablet, film coated, extended release and its route as oral.

The labeler, the company named on the label, is Teva Neuroscience, Inc.

FDA lists no Established Pharmacologic Class for it.

The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 68546-0479-56.

NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $7,534.82 for 30 tablets (30 × $251.16057 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The NDC

Other strengths, forms and brands

11 other products in the NADAC file share the FDA nonproprietary name deutetrabenazine with AUSTEDO XR 18 MG TABLET.

ProductPharmacies pay per unitMedicare per unit
AUSTEDO 6 MG TABLET
brand · tablet, coated
$83.20001 per EA filed
eff. 2026-09-23
$103.13655 per EA filed
Part D 2024 average
AUSTEDO 9 MG TABLET
brand · tablet, coated
$93.97081 per EA filed
eff. 2026-09-23
$103.13655 per EA filed
Part D 2024 average
AUSTEDO 12 MG TABLET
brand · tablet, coated
$125.02961 per EA filed
eff. 2026-09-23
$103.13655 per EA filed
Part D 2024 average
AUSTEDO XR 6 MG TABLET
brand · tablet, film coated, extended release
$83.0345 per EA filed
eff. 2026-09-23
$224.9188 per EA filed
Part D 2024 average
AUSTEDO XR 12 MG TABLET
brand · tablet, film coated, extended release
$166.76453 per EA filed
eff. 2026-09-23
$224.9188 per EA filed
Part D 2024 average
AUSTEDO XR 18 MG TABLET this page
brand · tablet, film coated, extended release
$251.16057 per EA filed
eff. 2026-09-23
$224.9188 per EA filed
Part D 2024 average
AUSTEDO XR 24 MG TABLET
brand · tablet, film coated, extended release
$250.63121 per EA filed
eff. 2026-09-23
$224.9188 per EA filed
Part D 2024 average
AUSTEDO XR 30 MG TABLET
brand · tablet, film coated, extended release
$332.33999 per EA filed
eff. 2026-09-23
$224.9188 per EA filed
Part D 2024 average
AUSTEDO XR 36 MG TABLET
brand · tablet, film coated, extended release
$416.75609 per EA filed
eff. 2026-09-23
$224.9188 per EA filed
Part D 2024 average
AUSTEDO XR 42 MG TABLET
brand · tablet, film coated, extended release
$498.13485 per EA filed
eff. 2026-09-23
$224.9188 per EA filed
Part D 2024 average
AUSTEDO XR 48 MG TABLET
brand · tablet, film coated, extended release
$500.84367 per EA filed
eff. 2026-09-23
$224.9188 per EA filed
Part D 2024 average
AUSTEDO XR TITR(12-18-24-30 MG)
brand · kit
$249.323 per EA filed
eff. 2026-01-01 to 2026-07-29
$224.9188 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-01-01, 2026-07-29, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

What Medicare paid

Medicare Part D paid $6,747.56 for 30 tablets, at an average of $224.9188 per EA in 2024 (2024-01-01 to 2024-12-31) for “Austedo XR” and “Deutetrabenazine”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 81,595 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for AUSTEDO XR 18 MG TABLET labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Austedo XR / Deutetrabenazine: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on brand name.